SCHEMBL3466348

SCHEMBL3466348

O=C1c2ccccc2C(=O)N1CCCCCn1c(Sc2ccc3c(c2)OCO3)nc2c(=O)[nH]cnc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.41
PKM P14618 2/20 0.41
TSHR P16473 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
TRAP1 Q12931 3/20 0.40
HSP90AB1 P08238 10/20 0.40
HSP90AA1 P07900 10/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3465171 0.87 TRAP1 (0.54) TRAP1HSP90AB1HSP90AA1HDAC3HDAC4
SCHEMBL3466126 0.87 HSP90AB1 (0.54) TRAP1HSP90AB1HSP90AA1HDAC3HDAC4
SCHEMBL3465846 0.85 HSP90AA1 (0.45) TSHRTRAP1HSP90AB1HSP90AA1HDAC3
SCHEMBL3124105 0.84 HSP90AA1 (0.43) KMT2ATSHRTRAP1HSP90AB1HSP90AA1
SCHEMBL3465614 0.76 KMT2A (0.39) KMT2APKMTSHRSMN1; SMN2TRAP1
SCHEMBL15970299 0.74 TRAP1 (0.71) TRAP1HSP90AB1HSP90AA1HDAC3HDAC4
SCHEMBL15970311 0.74 TRAP1 (0.71) TRAP1HSP90AB1HSP90AA1HDAC3HDAC4
SCHEMBL29421390 0.74 TRAP1 (0.71) TRAP1HSP90AB1HSP90AA1HDAC3HDAC4
SCHEMBL3465173 0.74 TSHR (0.33) KMT2ATSHRSMN1; SMN2TRAP1ALDH1A1
SCHEMBL3465434 0.73 TRAP1 (0.70) TRAP1HSP90AB1HSP90AA1HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100240656-A1 COMPOUNDS AS HSP90 INHIBITORS ORYZON GENOMICS, S.A. (ES) 2010-09-23 US disclosed
EP-2183221-A1 NEW COMPOUNDS AS HSP90 INHIBITORS Crystax Pharmaceuticals S.L. (ES) 2010-05-12 EP disclosed
WO-2009007399-A1 NEW COMPOUNDS AS HSP90 INHIBITORS CRYSTAX PHARMACEUTICALS, S.L. (ES) 2009-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100240656-A1 COMPOUNDS AS HSP90 INHIBITORS HSP90AB1, HSP90AB2P, HSP90AA1 KMT2A 4661/4885PKM 4037/4885TSHR 3642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.